维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Ischenko I"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cancer stem cells: how can we target them显示文摘	Ischenko I Seeliger H Schaffer M	2008	Curt Med Chem2008，15，：	1
2	Antisense inhibition of microrna-21 and microrna-221 in tumor-initiating stem-like cells modulates tumorigenesis,metastasis,and chemotherapy resistance in pancreatic cancer显示文摘	ZHAO Y ZHAO L ISCHENKO I	2015	Target Oncol2015，10，4：	1
3	Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma显示文摘	Zischek C Niess H Ischenko I	2009	Annals of Surgery2009，250，5：	1
4	The role of reactive oxygen species in membrane potential changes in macrophages and astrocytes显示文摘	Klyubin I V Kirpichnikova K M Ischenko A M	2000	Membr Cell Biol2000，13，：	1
5	The RON receptor tyrosine kinase promotes MSP- independent cell spreading and survival in breast epithelial cells 显示文摘	Feres K J Ischenko I Hayman MJ	2009	Oncogene2009，28，2：	1
6	EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinomacells显示文摘	Camaj P Seeliger H Ischenko I	2009	BiolChem2009，390，12：	1
7	Direct reprogramming by onco- genic Ras and Myc 显示文摘	Ischenko I Zhi J Moll UM	2013	Proc Natl Acad Sci USA2013，110，10：	1
8	EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic car- einoma cells显示文摘	Camaj P Seeliger H Ischenko I	2009	Biol Chem2009，390，12：	1
9	Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical impli- cations显示文摘	Ischenko I Seeliger H Kleespies A	2010	Langenbecks Arch Surg2010，395，1：	1
10	Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma显示文摘	ZISCHEK C NIESS H ISCHENKO I	2009	Ann Surg2009，250，5：	1
11	Antiangiogenic and anti-tumor activity of a novel vascular endothelial growth factorreceptor-2 tyrosine kinase inhibitor ZD6474 in a metastatichuman pancreatic tumor model显示文摘	Conrad C Ischenko I Kohl G	2007	Anticancer Drugs2007，18，5：	1
12	Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer显示文摘	Zhao Y Zhao L Ischenko I	2015	Target Oncol2015，10，4：	1
13	The C terminus of RON tyrosine kinase plays an autoinhibitory role显示文摘	YOKOYAMA N ISCHENKO I HAYMAN M J	2005	J Biol Chem2005，280，10：	1
14	EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma显示文摘	Seeliger H Camai P Ischenko I	2009	Mol Cancer Res2009，7，2：	1
15	Pancreatic cancerstem cells:new understanding of tumorigenesis,clinical im-plications显示文摘	Ischenko I Seeliger H Kleespies A	2010	Langenbecks Arch Surg2010，395，1：	1
16	Cancer stem cells:how can we target them显示文摘	Ischenko I Seeliger H Schaffer M		0，，30：	1
17	Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma显示文摘	Zischek C Niess H Ischenko I		0，，05：	1
18	Effect of Sic kinase inhi- bition on metastasis and tumor angiogenesis in human pancreatic cancer显示文摘	Ischenko I Guba M Yezhelyev M	2007	Angiogenesis2007，10，3：	1
19	Effect of Src ki- nase inhibition on metastasis and tumor angiogenesis in human pancreatic eancer显示文摘	Ischenko I Guba M Yezhelyev M	2007	Angiogenesis2007，35，10：	1
20	Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer显示文摘	Ischenko I Guba M Yezhelyev M	2007	Angiogenesis2007，10，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示